# Clinical Study of Generic and Brand Bupropion in Depression

> **NCT02209597** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 74 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Bupropion XL 300

## Key facts

- **NCT ID:** NCT02209597
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-25
- **Primary completion:** 2016-08-14
- **Final completion:** 2016-08-14
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209597, "Clinical Study of Generic and Brand Bupropion in Depression". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02209597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*